Concepedia

Rüdiger Koenen

RK

Statistics

Publications

4

Citations

109

H-Index

4

Active since

2014

Affiliations

Boehringer Ingelheim (Germany)(Current)

Boehringer Ingelheim (United States)

Rüdiger Koenen is an author at Boehringer Ingelheim (Germany) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

2014–2017

4

Publications

4

Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment

David Schnell, Susanne Buschke, Holger Fuchs et al. · Cancer Chemotherapy and Pharmacology · 2014 · 43 citations · Full text

, , +15

Effect of Gemfibrozil, Rifampicin, or Probenecid on the Pharmacokinetics of the SGLT2 Inhibitor Empagliflozin in Healthy Volunteers

Sreeraj Macha, Rüdiger Koenen, Regina Sennewald et al. · Clinical Therapeutics · 2014 · 39 citations

, , +6

Effect of Steady‐State Faldaprevir on Pharmacokinetics of Atorvastatin or Rosuvastatin in Healthy Volunteers: A Prospective Open‐Label, Fixed‐Sequence Crossover Study

Fenglei Huang, Kristell Marzin, Rüdiger Koenen et al. · The Journal of Clinical Pharmacology · 2017 · 16 citations

, , +11

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well‐Controlled Asthma

Andy Fowler, Rüdiger Koenen, James Hilbert et al. · The Journal of Clinical Pharmacology · 2017 · 11 citations

, , +7

1–4 of 4